• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于指纹的打分函数用于预测碳酸酐酶 II 抑制剂的结合模式。

Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.

机构信息

Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.

NEUROFARBA Department, Sezione di Scienze Farmaceutiche e Nutraceutiche, Università degli Studi di Firenze, Sesto Fiorentino, 50019 Florence, Italy.

出版信息

Int J Mol Sci. 2018 Jun 23;19(7):1851. doi: 10.3390/ijms19071851.

DOI:10.3390/ijms19071851
PMID:29937490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6073570/
Abstract

Carbonic anhydrase II (CAII) is a zinc-containing metalloenzyme whose aberrant activity is associated with various diseases such as glaucoma, osteoporosis, and different types of tumors; therefore, the development of CAII inhibitors, which can represent promising therapeutic agents for the treatment of these pathologies, is a current topic in medicinal chemistry. Molecular docking is a commonly used tool in structure-based drug design of enzyme inhibitors. However, there is still a need for improving docking reliability, especially in terms of scoring functions, since the complex pattern of energetic contributions driving ligand⁻protein binding cannot be properly described by mathematical functions only including approximated energetic terms. Here we report a novel CAII-specific fingerprint-based (IFP) scoring function developed according to the ligand⁻protein interactions detected in the CAII-inhibitor co-crystal structures of the most potent CAII ligands. Our IFP scoring function outperformed the ability of Autodock4 scoring function to identify native-like docking poses of CAII inhibitors and thus allowed a considerable improvement of docking reliability. Moreover, the ligand⁻protein interaction fingerprints showed a useful application in the binding mode analysis of structurally diverse CAII ligands.

摘要

碳酸酐酶 II(CAII)是一种含锌的金属酶,其异常活性与各种疾病有关,如青光眼、骨质疏松症和不同类型的肿瘤;因此,开发 CAII 抑制剂是药物化学中的一个热门课题,CAII 抑制剂可能成为治疗这些疾病的有前途的治疗剂。分子对接是基于结构的酶抑制剂药物设计中常用的工具。然而,对接可靠性仍然需要提高,特别是在评分函数方面,因为仅包括近似能量项的数学函数无法正确描述驱动配体-蛋白结合的复杂能量贡献模式。在这里,我们报告了一种新的基于 CAII 特异性指纹(IFP)的评分函数,该函数是根据 CAII-抑制剂共晶结构中最有效的 CAII 配体检测到的配体-蛋白相互作用开发的。我们的 IFP 评分函数优于 Autodock4 评分函数识别 CAII 抑制剂天然样对接构象的能力,从而大大提高了对接可靠性。此外,配体-蛋白相互作用指纹在结构多样的 CAII 配体的结合模式分析中具有有用的应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/eed48494425b/ijms-19-01851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/f158ff95e241/ijms-19-01851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/567a7775ecf9/ijms-19-01851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/73258c95c8e7/ijms-19-01851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/a13f8c1b6c4f/ijms-19-01851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/eed48494425b/ijms-19-01851-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/f158ff95e241/ijms-19-01851-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/567a7775ecf9/ijms-19-01851-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/73258c95c8e7/ijms-19-01851-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/a13f8c1b6c4f/ijms-19-01851-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/25a0/6073570/eed48494425b/ijms-19-01851-g005.jpg

相似文献

1
Development of a Fingerprint-Based Scoring Function for the Prediction of the Binding Mode of Carbonic Anhydrase II Inhibitors.基于指纹的打分函数用于预测碳酸酐酶 II 抑制剂的结合模式。
Int J Mol Sci. 2018 Jun 23;19(7):1851. doi: 10.3390/ijms19071851.
2
Prediction of binding modes and affinities of 4-substituted-2,3,5,6-tetrafluorobenzenesulfonamide inhibitors to the carbonic anhydrase receptor by docking and ONIOM calculations.通过对接和ONIOM计算预测4-取代-2,3,5,6-四氟苯磺酰胺抑制剂与碳酸酐酶受体的结合模式和亲和力。
J Mol Graph Model. 2016 Jan;63:38-48. doi: 10.1016/j.jmgm.2015.11.010. Epub 2015 Nov 18.
3
Structural aspects of isozyme selectivity in the binding of inhibitors to carbonic anhydrases II and IV.抑制剂与碳酸酐酶II和IV结合过程中同工酶选择性的结构方面
J Med Chem. 2002 Feb 14;45(4):888-93. doi: 10.1021/jm010163d.
4
Ranking Power of the SQM/COSMO Scoring Function on Carbonic Anhydrase II-Inhibitor Complexes.SQM/COSMO评分函数对碳酸酐酶II抑制剂复合物的排序能力。
Chemphyschem. 2018 Apr 5;19(7):873-879. doi: 10.1002/cphc.201701104. Epub 2018 Feb 19.
5
Mechanistic investigation of sulfonamide ligands as human carbonic anhydrase II inhibitors.磺酰胺配体作为人碳酸酐酶 II 抑制剂的作用机制研究。
Int J Biol Macromol. 2018 Dec;120(Pt A):1198-1207. doi: 10.1016/j.ijbiomac.2018.08.186. Epub 2018 Aug 31.
6
Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.针对人类碳酸酐酶IX催化结构域进行虚拟筛选、分子动力学及结合自由能计算以解读潜在先导化合物。
J Biomol Struct Dyn. 2017 Aug;35(10):2155-2168. doi: 10.1080/07391102.2016.1207565. Epub 2016 Aug 2.
7
5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.5-取代-(1,2,3-三唑-4-基)噻吩-2-磺酰胺类强烈抑制人碳酸酐酶 I、II、IX 和 XII:溶液和 X 射线晶体学研究。
Bioorg Med Chem. 2013 Sep 1;21(17):5130-8. doi: 10.1016/j.bmc.2013.06.041. Epub 2013 Jun 27.
8
Carbonic anhydrase inhibitors: Design, synthesis, kinetic, docking and molecular dynamics analysis of novel glycine and phenylalanine sulfonamide derivatives.碳酸酐酶抑制剂:新型甘氨酸和苯丙氨酸磺酰胺衍生物的设计、合成、动力学、对接及分子动力学分析
Bioorg Med Chem. 2015 Dec 1;23(23):7353-8. doi: 10.1016/j.bmc.2015.10.009. Epub 2015 Oct 23.
9
Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase II.磺酰脲衍生物作为人碳酸酐酶 II 的潜在抑制剂的意义。
Int J Biol Macromol. 2018 Aug;115:961-969. doi: 10.1016/j.ijbiomac.2018.04.131. Epub 2018 Apr 26.
10
Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.鉴定 3,4-二氢异喹啉-2(1H)-磺酰胺类化合物作为有效的碳酸酐酶抑制剂:合成、生物学评价和酶-配体 X 射线研究。
J Med Chem. 2010 Mar 25;53(6):2401-8. doi: 10.1021/jm9014026.

引用本文的文献

1
A Machine Learning Platform for Isoform-Specific Identification and Profiling of Human Carbonic Anhydrase Inhibitors.用于人碳酸酐酶抑制剂异构体特异性鉴定和分析的机器学习平台。
Pharmaceuticals (Basel). 2025 Jul 5;18(7):1007. doi: 10.3390/ph18071007.
2
Prediction of activity and selectivity profiles of human Carbonic Anhydrase inhibitors using machine learning classification models.使用机器学习分类模型预测人类碳酸酐酶抑制剂的活性和选择性概况。
J Cheminform. 2021 Mar 6;13(1):18. doi: 10.1186/s13321-021-00499-y.
3
Application of MM-PBSA Methods in Virtual Screening.

本文引用的文献

1
Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors.含苯磺酰胺部分的新型4-官能化1,5-二芳基-1,2,3-三唑类化合物作为碳酸酐酶I、II、IV和IX抑制剂的合成。
Eur J Med Chem. 2018 Apr 25;150:678-686. doi: 10.1016/j.ejmech.2018.03.030. Epub 2018 Mar 14.
2
Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.新型2-(2-芳基甲基硫代-4-氯-5-甲基苯磺酰基)-1-(1,3,5-三嗪-2-基氨基)胍衍生物:对人碳酸酐酶胞质同工酶I和II以及跨膜肿瘤相关同工酶IX和XII的抑制作用、抗癌活性及分子模拟研究
Eur J Med Chem. 2018 Jan 1;143:1931-1941. doi: 10.1016/j.ejmech.2017.11.005. Epub 2017 Nov 4.
3
MM-PBSA 方法在虚拟筛选中的应用。
Molecules. 2020 Apr 23;25(8):1971. doi: 10.3390/molecules25081971.
4
Development of a cheminformatics platform for selectivity analyses of carbonic anhydrase inhibitors.开发用于碳酸酐酶抑制剂选择性分析的 cheminformatics 平台。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):365-371. doi: 10.1080/14756366.2019.1705291.
5
Novel 8-Substituted Coumarins That Selectively Inhibit Human Carbonic Anhydrase IX and XII.新型 8-取代香豆素类化合物选择性抑制人碳酸酐酶 IX 和 XII
Int J Mol Sci. 2019 Mar 10;20(5):1208. doi: 10.3390/ijms20051208.
6
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors.基于计算的苯(哌嗪-1-基)甲酮衍生物的发现作为可还原的单酰基甘油脂肪酶(MAGL)抑制剂。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):589-596. doi: 10.1080/14756366.2019.1571271.
7
Target-based drug discovery through inversion of quantitative structure-drug-property relationships and molecular simulation: CA IX-sulphonamide complexes.基于定量构效关系和分子模拟的靶向药物发现:CAIX-磺胺复合物。
J Enzyme Inhib Med Chem. 2018 Dec;33(1):1430-1443. doi: 10.1080/14756366.2018.1511551.
Enhance the performance of current scoring functions with the aid of 3D protein-ligand interaction fingerprints.借助三维蛋白质-配体相互作用指纹图谱提高当前评分函数的性能。
BMC Bioinformatics. 2017 Jul 18;18(1):343. doi: 10.1186/s12859-017-1750-5.
4
Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis.从地中海贻贝(Mytilus galloprovincialis)外套膜中纯化得到的天然α-碳酸酐酶的生化特性。
J Enzyme Inhib Med Chem. 2017 Dec;32(1):632-639. doi: 10.1080/14756366.2017.1284069.
5
Structure and function of carbonic anhydrases.碳酸酐酶的结构与功能。
Biochem J. 2016 Jul 15;473(14):2023-32. doi: 10.1042/BCJ20160115.
6
Reliability analysis and optimization of the consensus docking approach for the development of virtual screening studies.可靠性分析和共识对接方法的优化,用于虚拟筛选研究的开发。
J Enzyme Inhib Med Chem. 2016;31(sup2):167-173. doi: 10.1080/14756366.2016.1193736. Epub 2016 Jun 17.
7
PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design.PDEStrIAn:一个磷酸二酯酶结构与配体相互作用注释数据库,作为基于结构的药物设计工具。
J Med Chem. 2016 Aug 11;59(15):7029-65. doi: 10.1021/acs.jmedchem.5b01813. Epub 2016 Mar 18.
8
Identification of a new STAT3 dimerization inhibitor through a pharmacophore-based virtual screening approach.通过基于药效团的虚拟筛选方法鉴定一种新型STAT3二聚化抑制剂。
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1011-7. doi: 10.3109/14756366.2015.1079184. Epub 2015 Aug 24.
9
Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.探究碳酸酐酶活性位点的“双极性”本质:含1,3-恶唑-5-基部分的芳基磺酰胺作为胞质碳酸酐酶I和II同工型的皮摩尔级抑制剂
Eur J Med Chem. 2015 Aug 28;101:334-47. doi: 10.1016/j.ejmech.2015.06.022. Epub 2015 Jun 25.
10
Application of a FLAP-consensus docking mixed strategy for the identification of new fatty acid amide hydrolase inhibitors.应用 FLAP 一致对接混合策略鉴定新型脂肪酸酰胺水解酶抑制剂。
J Chem Inf Model. 2015 Mar 23;55(3):667-75. doi: 10.1021/ci5006806. Epub 2015 Mar 12.